ArticleIntestinal research2016

Efficacy and safety of two pH-dependent-release mesalamine doses in moderately active ulcerative colitis: a multicenter, randomized, double-blind, parallel-group study.

Yasuo Suzuki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.